Vaginal versus intrauterine extra-amniotic administration of misoprostol for second-trimester pregnancy termination; a randomized clinical trial
Introduction: Misoprostol is a widely used prostaglandin to terminate pregnancy in the second trimester. The route of drug administration has a significant effect on the quality of treatment. Objectives: In this study, we aimed to compare efficacy and adverse effects of vaginal and intrauterine extr...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nickan Research Institute
2022
|
Subjects: | |
Online Access: | View Fulltext in Publisher |